Gentian Diagnostics ASA – conversion to public limited liability company registered

07. May 2021 | 1 min read

Moss, 7 May 2021
Reference is made to the stock exchange announcement made on 4 May 2021 by Gentian Diagnostics AS (the "Company") regarding the annual general meeting held the same date.
The resolutions made by the general meeting, inter alia amendments to the Company's articles of association, including the conversion of the Company into a public limited liability company and change of company name have now been registered with the Norwegian Register of Business Enterprises. The new name of the Company is Gentian Diagnostics ASA.
 
For further information, please contact:
Hilja Ibert CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no 
Cell Phone: +47 919 05 242

Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

You may also read


Jun 18, 2021 - Kristin Hart

Gentian Diagnostics: Invitation to virtual presentation at 24 June

Gentian Diagnostics ASA has the pleasure of inviting to a virtual presentation on Thursday 24 June 2021 at..

Jun 18, 2021 - Kristin Hart

Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests

Moss, 18.06.2021 Gentian Diagnostics ASA, is a fast-growing developer and manufacturer of innovative and..

May 10, 2021 - Kristin Hart

Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs

Moss, 7 May 2021 Gentian Diagnostics ASA (the "Company") is pleased to announce that it has today submitted..